Applying a one year lag period, the hazard ratio for thyroid cancer comparing GLP1 receptor agonists with SGLT2 inhibitors was 0.98 (95% confidence interval 0.62 to 1.53).18 Here, GLP1R is linked to thyroid gland carcinoma.